Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 May;46(5):614–622. doi: 10.1165/rcmb.2011-0359OC

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2012 by the American Thoracic Society

PMC Copyright notice

Figure 6. — Effects of t-TUCB and Rolipram on oxylipins in the lung. (A) Major oxylipins prostaglandin E2 (PGE2), (B) 13-hydroxyoctadecadienoic acid, and (C) 5-oxo-6,8,11,14-eicosatetraenoic acid and (D) the epoxyeicosatrienoic acids (EETs)/diols ratio are shown. Data are expressed as means ± SEM for 4–8 animals/group. *P < 0.05, TS-exposed groups were significantly different from the control group. ^†P < 0.05, treatment group with sEHI t-TUCB was significantly different from the TS vehicle group. ^‡P < 0.05, treatment group with Rolipram was significantly different from the TS vehicle group.